Lumacyte LLC

General information

LumaCyte produces microfluidic and optics based instruments and
sub-components that enable cell biologists, biomedical researchers,
pharmaceutical and biotechnology companies to characterize, select, and
sort mammalian cell samples without the use of antibody labels. Radiance
can be used for rapid viral infectivity as a replacement for plaque assay
and TCID50 which are slow, tedious, labor intensive, and highly variable.
Radiance can measure infectivity directly from a bioreactor within minutes
of colleting a sample.